Healx Logo

Latest news and articles

Filter

All
News
In the media
Events
In the media
How third-generation drug discovery is transforming rare disease treatment development
Charlotte Chorley
In the media
Europe’s AI laws will cost companies a small fortune – but the payoff is trust
Charlotte Chorley
Event
Biotech Showcase 2022
10 January 2022
38 days until event
Patrick White
Event
Precision Medicine World Conference 2022
26 January 2022
54 days until event
Patrick White
In the media
Digital technology promises to transform healthcare
Charlotte Chorley
In the media
Dr. Tim Guilliams, Co-founder of AI Drug Development Company, Healx on Going From Startup CxO to Scale-up CxO
Charlotte Chorley
News
Healx pledges $25,000 to AKU Society patient registry campaign
Patrick White
In the media
Clinical Trials Expand For AI-Designed Drug To Treat Fragile X Syndrome
Patrick White
In the media
UK startup Healx to begin clinical trial on repositioned drug for Fragile X Syndrome
Patrick White
News
Healx receives IND and Orphan Drug Designation for fragile X clinical trial
Patrick White
In the media
Healx is solving a problem for 400m people by repurposing medicine
Charlotte Chorley
News
Healx launches AI-powered indication expansion partnership with Ono Pharmaceutical Co. Ltd.
Charlotte Chorley
In the media
Viagra can teach us a lot about treating rare diseases
Charlotte Chorley
In the media
How to treat rare diseases with existing drugs — with Meri Williams, CTO of Healx
Charlotte Chorley
In the media
The Post-Covid Future of AI for Drug Development
Charlotte Chorley
In the media
12 Clusters of Tech Report: East of England
Charlotte Chorley
News
Healx appoints ex-Dyson lead, Andrew Watson, as VP of Artificial Intelligence
Charlotte Chorley
In the media
Meet the man using AI to hunt down the world's rarest diseases
Charlotte Chorley
News
Healx launches partnership with Ataxia UK and FARA to find treatments for rare neurodegenerative condition
Charlotte Chorley
In the media
AI in Drug Discovery Starts to Live Up to Hype
Charlotte Chorley
In the media
Healx: How AI is rewriting the economics of rare disease drug discovery
Charlotte Chorley
In the media
One year on: How AI can supercharge the healthcare of the future
Charlotte Chorley
In the media
Healx and PKD Charity use AI to find cures for rare kidney diseases
Charlotte Chorley
News
Healx and the PKD Charity collaborate to apply AI to the discovery of novel treatments for rare kidney diseases
Charlotte Chorley
In the media
Rare Disease Day 2021 Radio Blast
Charlotte Chorley
In the media
5 things you need to know about growing a tech team under Covid-19
Charlotte Chorley
In the media
Healx joins Mission: Cure to speed up rare disease treatments
Charlotte Chorley
News
Healx teams up with Mission: Cure to discover and advance the world’s first treatments for chronic pancreatitis
Charlotte Chorley
In the media
Meet the 35 healthcare startups VCs say will take off in 2021
Charlotte Chorley
In the media
Building tech teams
Charlotte Chorley
News
Healx’s Rare Treatment Accelerator 2.0 opens to unlock the power of repurposed drugs for rare diseases
Charlotte Chorley
In the media
How we made it: Top tips from four successful tech entrepreneurs
Charlotte Chorley
In the media
Meri Williams: Driving tech strategy at a start-up using AI for drug discovery
Charlotte Chorley
In the media
How AI is offering hope to millions with rare diseases
Charlotte Chorley
In the media
Tech.eu Podcast #187: Nvidia + Arm, Klarna’s funding, interview with Meri Williams of Healx
Charlotte Chorley
In the media
CTO Talk: Q&A with Healx’s Meri Williams
Charlotte Chorley
News
Interview with Dr Allyson Berent, Chief Scientific Officer at the Foundation for Angelman Syndrome Therapeutics
Charlotte Chorley
In the media
Healx uses AI to find drugs for Angelman Syndrome
Charlotte Chorley
In the media
Digital Health 150: The Digital Health Startups Transforming The Future Of Healthcare
Charlotte Chorley
News
Healx teams up with the Foundation for Angelman Syndrome Therapeutics to accelerate novel treatments towards the clinic
Charlotte Chorley
News
Q+A with Dr Kate Adcock, Director of Research and Innovation at Muscular Dystrophy UK
michelle.harrison@healx.io
In the media
The top 16 companies using AI to revolutionise drug discovery
michelle.harrison@healx.io
News
Healx and Muscular Dystrophy UK join forces to find new treatments for rare muscle-wasting diseases
michelle.harrison@healx.io
In the media
How AI technology is leading the charge against Covid-19
Charlotte Chorley
In the media
Meet Meri Williams, the super CTO
michelle.harrison@healx.io
News
Meri Williams joins Healx as Chief Technology Officer
michelle.harrison@healx.io
In the media
Biotechs harness AI in battle against COVID-19
michelle.harrison@healx.io
In the media
How AI is fighting COVID-19: the companies using intelligent tech to find new drugs
michelle.harrison@healx.io
In the media
Our thriving healthtech sector is proving its worth on the coronavirus frontline
michelle.harrison@healx.io
In the media
Coronavirus: AI steps up in battle against COVID-19
michelle.harrison@healx.io
In the media
Healx trains AI to find COVID-19 combination therapies
michelle.harrison@healx.io
In the media
Healx links with CTF to develop neurofibromatosis therapies
michelle.harrison@healx.io
News
Healx partners with Children’s Tumor Foundation to progress neurofibromatosis treatments; recruits patient advocate to lead collaborative drug discovery efforts
michelle.harrison@healx.io
News
Healx using artificial intelligence to find combination drug treatments for COVID-19
michelle.harrison@healx.io
In the media
Promoting #EachforEqual this International Women’s Day
michelle.harrison@healx.io
News
Healx announces first three Rare Treatment Accelerator partnerships
michelle.harrison@healx.io
In the media
Repurposing drugs to fight cancer
michelle.harrison@healx.io
News
Healx appoints Dr Anthony Hall as Chief Medical Officer
michelle.harrison@healx.io
In the media
Healx, Boehringer link for rare neurological disease therapy
michelle.harrison@healx.io
In the media
Boehringer partners with Healx for AI-based drug discovery
michelle.harrison@healx.io
In the media
Boehringer Ingelheim pairs with AI firm Healx to repurpose assets for rare neurological disorders
michelle.harrison@healx.io
News
Healx joins forces with Boehringer Ingelheim to discover new treatment approaches for rare neurological diseases
michelle.harrison@healx.io
In the media
Healx invites patient groups to apply as it commits $20m to treatment accelerator
michelle.harrison@healx.io
In the media
AI startup Healx looks to find repurposable drugs for rare diseases
michelle.harrison@healx.io
In the media
Healx backs Rare Treatment Accelerator with $20m
michelle.harrison@healx.io
News
Healx commits $20 million to launch Rare Treatment Accelerator programme; Appoints Dr Bruce Bloom as Chief Collaboration Officer to lead initiative
michelle.harrison@healx.io
News
Michale Bouskila-Chubb recognised in 50 Movers and Shakers in BioBusiness Report
michelle.harrison@healx.io
News
Healx scientists present two new papers at EMNLP 2019 in Hong Kong
michelle.harrison@healx.io
In the media
Channeling the power of AI into personalising medicine
michelle.harrison@healx.io
In the media
Viagra inventor raises funds to test AI-generated treatments
michelle.harrison@healx.io
In the media
Healx raises $56m Series B to use AI to find treatments for rare diseases
michelle.harrison@healx.io
In the media
Months after $10m Series A, rare disease AI upstart Healx hauls in $56m in fresh funding
michelle.harrison@healx.io
News
Healx secures $56m in Series B financing, launches global accelerator programme for rare diseases
michelle.harrison@healx.io
In the media
AI for drug repurposing: interview with Dr Ian Roberts
michelle.harrison@healx.io
In the media
Healx in the media
michelle.harrison@healx.io
News
Healx partners with the ICR to develop potential new AI-derived treatments for rare childhood cancer, DIPG
michelle.harrison@healx.io
In the media
How women can make the most of the tech boom
michelle.harrison@healx.io
In the media
UK drug discovery startup Healx taps GSK, Astex alum as CSO
michelle.harrison@healx.io
News
Dr Neil Thompson Appointed CSO of Healx to spearhead drug discovery expansion
hello@douglassdigital.com
In the media
SmartPeople: Dr Tim Guilliams
michelle.harrison@healx.io
In the media
How machines could mine forgotten data
In the media
25 European medtech and life sciences start-ups to watch in 2019
In the media
Maserati top 100: celebrating innovators in 2019 (The Times)
In the media
How a medical tech company is using AI to cure rare diseases
In the media
Meet the drug hunters: the scientists determined to cure rare diseases (The Independent)
hello@douglassdigital.com
In the media
Healx and Boston Children’s Hospital link up for Barth syndrome drug discovery
hello@douglassdigital.com
News
Healx pushing new drug development model in rare diseases with Barth Syndrome Foundation
hello@douglassdigital.com
In the media
Healx and ICR to develop AI-derived treatments for rare childhood cancer
michelle.harrison@healx.io
In the media
Ahead of the curve, ahead of the cure
hello@douglassdigital.com
In the media
How one startup is using AI to find cures for 100 rare diseases by 2025
hello@douglassdigital.com
In the media
10 cool start-ups from Cambridge to watch
In the media
Healx announce the appointment of Kate Hilyard as Chief Operating Officer (COO)
News
Healx welcomes Kate Hilyard, leading pharma executive, to drive the integration of AI with drug discovery for rare diseases
Charlotte Chorley
In the media
Inventor of Viagra raises funding to treat 7,000 rare diseases
hello@douglassdigital.com
In the media
Healx secures $10 million Series A to treat rare diseases
In the media
Healx lands $10m Series A to accelerate drug discovery
hello@douglassdigital.com
News
Healx raises $10m as investors back AI to find rare disease treatments faster
Charlotte Chorley
News
Global investors engage in potential Series A
Charlotte Chorley
News
Healx data scientist wins poster prize for finding new links between rare diseases
Charlotte Chorley
News
Healx scientist publishes paper predicting effectiveness of combinations of antibiotics
Charlotte Chorley
News
Healx listed as a Leading Global Innovator in 'Disrupt 100' list
Charlotte Chorley
News
Healx CEO to speak at Milken Institute Global Conference
Charlotte Chorley
News
Healx celebrate 3 years of rare disease drug repurposing
Charlotte Chorley
News
Healx: Key player in Global Drug Repurposing Open Call
Charlotte Chorley
News
Invitation to support cancer prevention
Charlotte Chorley
News
Healx CEO meets HM Queen Elizabeth II
Charlotte Chorley
In the media
The Killer 50 The 50 hottest disruptive technology companies
News
The hunt for a new treatment for neuroblastoma
Charlotte Chorley
News
Healx CEO gives opening keynote at Orphan Drug Conference
Charlotte Chorley
News
Healx CSO presents results at CDKL5 Forum conference
Charlotte Chorley
News
Hermann Hauser KBE backs Healx to combat rare diseases
Charlotte Chorley
News
Healx announces £1.5m investment led by Jonathan Milner
Charlotte Chorley
News
Healx wins Cambridge Graduate Business of the Year!
Charlotte Chorley
News
Healx finalists of Pitch@Palace
Charlotte Chorley
In the media
Using genomic signatures to match best drugs for rare disease patients
michelle.harrison@healx.io
News
Drug repurposing webinar, 16 February
Charlotte Chorley
News
Healx launch project with aPODD to identify new treatment for medulloblastoma
Charlotte Chorley
News
New economics for old drugs
Charlotte Chorley
News
Healx Chair publishes in Nature Reviews Drug Discovery
Charlotte Chorley
News
Personalised medicine: putting patients at the centre
Charlotte Chorley
News
Technology provides hope for rare diseases
Charlotte Chorley
News
Chairing Boston Repurposing Summit
Charlotte Chorley
News
Healx supports Cambridge Rare Disease Summit 2015
Charlotte Chorley
News
Healx awarded Life Science Business of the Year
Charlotte Chorley
In the media
Rare disease pioneer completes £300k seed round
In the media
Cambridge startup launches rare disease network
michelle.harrison@healx.io
In the media
Cambridge startup hopes to find cure for US boy’s rare disease
michelle.harrison@healx.io